DB
AVEO

Dmitry Balyasny’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Dmitry Balyasny’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,445,068
Closed -$21.6M – 3443
2022
Q4 		$21.6M Buy
+1,445,068
New +$20M 0.06% 461

Dmitry Balyasny's AVEO Position: Q1 2023 in Review

Dmitry Balyasny sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 1,445,068 shares — an estimated $21.6M sold.

Dmitry Balyasny first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $21.6M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Dmitry Balyasny reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Dmitry Balyasny sold 1,445,068 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $21.6M.
  • Dmitry Balyasny first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Dmitry Balyasny's AVEO Pharmaceuticals, Inc. position peaked at $21.6M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.